Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective

Alexis J Hure*, Shanthi Ramanathan, Simon Deeming, Gemma A Figtree, Garry Jennings, Jacqui Webster, Rachael L Morton, Julie Redfern, Kerry Doyle, Stephen J Nicholls, Stephanie Blows, Catherine Kellick, Martin McNamara, Andrew Searles

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

1 Citation (Scopus)


This aim of this paper is to set the scene for the need for impact assessment and return on investment in funded cardiovascular research in Australia, starting with the historical perspective on waste in health and medical research. Recently there has been a substantial move from discussion and policy about the need for research translation, into practice and application via the evolution of funding streams like the Australian Medical Research Future Fund (MRFF). Health and medical research funders play a critical role in both setting the expectations for research translation and impact and helping researchers to meet these expectations. As a leading cause of death, cardiovascular disease is a national health priority, recognised as such with a AUD$220 million MRFF allocation to the Cardiovascular Health Mission. Focussing on cardiovascular research, we address some of the barriers researchers face in prospectively planning for research translation and impact assessment, and call for an ecosystem that supports a return on investment for all stakeholders, especially the community and patient end-users.

Original languageEnglish
Pages (from-to)1442-1448
Number of pages7
JournalHeart Lung and Circulation
Issue number10
Publication statusPublished - Oct 2021
Externally publishedYes


Dive into the research topics of 'Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective'. Together they form a unique fingerprint.

Cite this